24880-45-3
Chemical Structure
Docosapentaenoic acid (22n-3)
Synonym(s): Clupanodonic acid
- CAS No.: 24880-45-3
- Formula:C22H34O2
- Molecular Weight:330.50
IUPAC Name: (7Z,10Z,13Z,16Z,19Z)-docosa-7,10,13,16,19-pentaenoic acid
InChIKey: YUFFSWGQGVEMMI-JLNKQSITSA-N
SMILES: CC/C=C\C/C=C\C/C=C\C/C=C\C/C=C\CCCCCC(O)=O
Biological Activity: Docosapentaenoic acid (22n-3) is a component of phospholipids. Docosapentaenoic acid 22n-3 has inhibitory activity against α-amylase and α-glucosidase, with IC50s value of 17 μg/mL and 22 μg/mL, respectively. Docosapentaenoic acid 22n-3 increases cell vitality. Docosapentaenoic acid 22n-3 has a weak anti-inflammatory effect[1][2][3].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Docosapentaenoic acid (22n-3) | 99.87% | Docosapentaenoic acid (22n-3) is a component of phospholipids. Docosapentaenoic acid 22n-3 has inhibitory activity against α-amylase and α-glucosidase, with IC50s value of 17 μg/mL and 22 μg/mL, respectively. Docosapentaenoic acid 22n-3 increases cell vitality. Docosapentaenoic acid 22n-3 has a weak anti-inflammatory effect. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
-
Similarity Score 0.97
HY-N7833Heneicosapentaenoic acid -
Similarity Score 0.97
HY-N162408(Z),11(Z),14(Z),17(Z),20(Z)-Tricosapentaenoic acid -
Similarity Score 0.94
HY-W752039(9Z,12Z,15Z,18Z,21Z)–Tetracosapentaenoic acid -
Similarity Score 0.94
HY-B0660REicosapentaenoic Acid (Standard) -
Similarity Score 0.93
HY-1800417(Z),10(Z),13(Z),16(Z)-Nonadecatetraenoic acid -
Similarity Score 0.93
HY-125140ω-3 Arachidonic acid -
Similarity Score 0.91
HY-120958Nisinic acid -
Similarity Score 0.91
HY-113120Stearidonic acid -
Similarity Score 0.91
HY-1263554,7,10,13,16-Docosapentaenoic acid -
Explore the MedChemAI to find more analogs
References
- [1]. Sinclair HM, et al. Essential fatty acids in perspective. Hum Nutr Clin Nutr. 1984 Jul;38(4):245-60. [Content Brief]
- [2]. Peng H, et al. Cartilaginous Metabolomics Reveals the Biochemical-Niche Fate Control of Bone Marrow-Derived Stem Cells. Cells. 2022 Sep 21;11(19):2951. [Content Brief]
- [3]. Sivaramakrishnan R, et al. In vitro anti-diabetic and anti-inflammatory activities of metabolites isolated from Marine Sponge, Heteronema erecta (Keller, 1889) and its in silico studies[J]. Research Journal of Biotechnology Vol, 2020, 15: 12.
